Ischemic mitral regurgitation: modern evidence based echocardiography diagnosis, quantification and risks stratification review

  • S. A. Rudenko National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine, Kyiv, Ukraine
  • S. V. Potashev National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine, Kyiv, Ukraine
  • L. M. Hrubiak National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine, Kyiv, Ukraine
  • O. A. Mazur National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine, Kyiv, Ukraine
  • O. K. Gogayeva National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine, Kyiv, Ukraine
  • A. V. Rudenko National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.30702/ujcvs/19.3712/08009-016
Keywords: coronary arteries disease, ischemic mitral regurgitation, echocardiography

Abstract

Ischemic mitral regurgitation (IMR) is a frequent complication in the patients after acute myocardial infarction (AMI) or in ischemic cardiomyopathy (ICM), associated with significant prognosis worsening. Mitral valve (MV) involvement may be primary (organic MR) or secondary (functional MR). Primary MR develops because of mitral subvalvular apparatus rupture as an AMI complication. Secondary IMR develops in the conditions of normal MV cusps and chords structure because of balance impairment between MV closure and tension forces secondary to left ventricle (LV) geometry alterations. According to evidence data both scenarios of IMR are associated with at least one major coronary artery critical stenosis (>70%). Secondary IMR is the most frequent consequence of ischemic cardiomyopathy. IMR diagnosis is associated with elevated patients mortality compared to those without it. It has been shown, that survival within patients with IMR after AMI down to 40% in case of moderate-to-severe IMR, compared to 62% in the patients with mild IMR or 84% in the patients without IMR at all. Pathophysiological mechanisms of IMR are not fully understood, but it is well known, that IMR is a complex entity, having left chambers, especially left ventricle (LV) remodeling as a key cause. Echocardiography (EchoCG) significantly contributes to understanding the underlying mechanisms of IMR. The aim of this review is to summarize modern evidence based data about IMR mechanisms and analysis of contemporary EchoCG indices for diagnosis, evaluation and risks stratification in the patients with IMR. IMR develops in approximately 20% of patients after AMI with increasing occurrence over past years, significantly influencing patients’ prognosis. IMR is a complex and dynamic entity, where LV remodeling is the main factor of MV dysfunction. EchoCG plays the clue role in IMR diagnosis giving the detailed information about its mechanisms and severity grading. Comprehensive EchoCG in the patients with coronary arteries disease (CAD) allows a better and comprehensive approach in risks stratification and optimal surgical IMR treatment planning.

References

  1. Izquierdo-Gуmez MM, Marн-Lуpez B, Lacalzada-Almeida J. Ischaemic mitral valve regurgitation. e-Journal of Cardiology Practice[Internet]. 2018 May [cited 2019 Nov];16:[about 1 p.]. Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-16/Ischaemic-mitral-valve-regurgitation
  2. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard L A, Badano L, Zamorano JL. Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611–44.
  3. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Munoz DR, Rosenhek R, Sjogren S, Tornos P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739–91.
  4. Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, Roger VL. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005 Jan 25;111(3):295–301.
  5. American Association for Thoracic Surgery Ischemic Mitral Regurgitation Consensus Guidelines Writing Committee; Kron IL, Acker MA, Adams DH, Ailawadi G, Bolling SF, Hung JW, Lim DS, LaPar DJ, Mack MJ, OґGara PT, Parides MK, Puskas JD. 2015 The American Association for Thoracic Surgery Consensus Guidelines: Ischemic mitral valve regurgitation. J Thorac Cardiovasc Surg. 2016;151(4):940–56.
  6. Azpitarte J, Alonso AM, Gallego FG, Gonzбlez JM, ParйC, Tello A. [Guidelines of the Spanish Society of Cardiology on valve heart disease]. Rev Esp Cardiol. 2000;53:1209–78. Spanish.
  7. Lancellotti P, Troisfontaines P, Toussaint A, Pierard LA. Prognostic Importance of Exercise-Induced Changes in Mitral Regurgitation in Patients With Chronic Ischemic Left Ventricular Dysfunction. Circulation. 2003 Oct 7;108(14):1713–7.
  8. Tcheng JE, Jackman JD, Nelson CL, Gardner LH, Smith LR, Rankin JS, Califf RM, Stack RS. Outcome of Patients Sustaining Acute Ischemic Mitral Regurgitation during Myocardial Infarction. Ann Intern Med. 1992 Jul 1;117(1):18–24.
  9. Grigioni F, Detaint D, Avierinos J, Scott C, Tajik J, Enriquez-Sarano M. Contribution of Ischemic Mitral Regurgitation to Congestive Heart Failure After Myocardial Infarction. J Am Coll Cardiol. 2005 Jan 18;45(2):260–7.
  10. Iung B. Management of ischaemic mitral regurgitation. Heart. 2003 Apr;89(4):459–64.
  11. Messika-Zeitoun D, Fung Yiu S, Grigioni F, Enriquez-Sarano M. [Role of echocardiography in the detection and prognosis of ischemic mitral regurgitation]. Rev Esp Cardiol. 2003 Jun;56(6):529-34. Spanish.
  12. Zeng X, Levine RA, Hua L, Morris EL, Kang Y, Flaherty M, Morgan NV, Hung J. Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color Doppler 3D echocardiography. Circ Cardiovasc Imaging. 2011 Sep;4(5):506–13.
  13. Gentry JL, Phelan D, Desai MY, Griffin BP. The Role of Stress Echocardiography in Valvular Heart Disease: A Current Appraisal. Cardiology. 2017;137(3):137–50.
  14. Lang RM, Tsang W, Weinert L, Mor-Avi V, Chandra S. Valvular heart disease. The value of 3-dimensional echocardiography. J Am Coll Cardiol. 2011 Nov 1;58(19):1933–44.
  15. Starling MR, Kirsh MM, Montgomery DG, Gross MD. Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol. 1993 Jul;22(1):239–50.
  16. Matsumura T, Ohtaki E, Tanaka K, Misu K, Tobaru T, Asano R, Nagayama M, Kitahara K, Umemura J, Sumiyoshi T, Kasegawa H, Hosoda S. Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair. J Am Coll Cardiol. 2003 Aug 6;42(3):458–63.
Published
2020-01-07
How to Cite
Rudenko, S. A., Potashev, S. V., Hrubiak, L. M., Mazur, O. A., Gogayeva, O. K., & Rudenko, A. V. (2019). Ischemic mitral regurgitation: modern evidence based echocardiography diagnosis, quantification and risks stratification review. Ukrainian Journal of Cardiovascular Surgery, (4 (37), 9-16. https://doi.org/10.30702/ujcvs/19.3712/08009-016
Issue
Ukrainian Journal of Cardiovascular Surgery No 4 (37) 2019
Section
ISCHEMIC HEART DISEASE

Most read articles by the same author(s)